Skip to main content

You’re not alone. Call 988 to connect to the National Suicide and Crisis Lifeline.

Join Us    |    Contact

DEA Extends COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications for Now

The U.S. Drug Enforcement Administration (DEA) on Wednesday said it will extend its COVID-19 telemedicine flexibilities for prescription of controlled medications as the agency works to determine how to move forward in a way that gives Americans access to needed medicine with the appropriate safeguards. An announcement from DEA noted the agency received a record number of comments on its proposed telemedicine rules, which prompted DEA and HHS to submit a draft temporary rule to the Office of Management and Budget requesting an extension. NABH submitted comments on this matter (see CEO Update, April 28, 2023). “Further details about the rule will become public after its full publication in the Federal Register,” the announcement said.

NABH Education & Research Foundation Webpage Now Features Grants & Funding Opportunities

The NABH Research and Education Foundation has updated its webpage with a section devoted to potential funding resources and opportunities for behavioral healthcare organizations and their employees. To access the Foundation’s webpage, visit NABH’s homepage and locate the “NABH Foundation” tab in the navigation menu. From there, hover over the tab to find a drop-down menu with the following sections: About, Grants & Funding Opportunities, Resources, and Contribute. We urge you to visit the page and search for potential funding opportunities, which NABH also includes in CEO Update, the association’s weekly e-newsletter. Please contact foundation@nabh.org if you have a grant or other funding opportunity to share. Thank you!

CMS to Require COVID-19 Vaccinations for Medicare and Medicaid Providers

[vc_row][vc_column][vc_column_text]
  • CMS is requiring that all staff of certain providers and suppliers participating in the Medicare or Medicaid programs receive the COVID-19 vaccine.
  • The IFR does not allow for weekly testing in lieu of vaccination.
  • The agency expressly preserves an employer’s right to require its employees to be fully vaccinated, regardless of the exemptions provided by the IFC.
Today, the Centers for Medicare and Medicaid Services (CMS) issued an interim final rule with comment (IFC), establishing COVID-19 vaccination requirements for staff at specified Medicare- and Medicaid-certified providers and suppliers. The IFC, entitled, “Medicare and Medicaid Programs: Omnibus COVID-19 Health Care Staff Vaccination” (rule; press release; FAQ) stipulates that all staff members, including those who perform their duties outside of a formal clinical setting, of certain providers and suppliers participating in the Medicare and Medicaid programs must be fully vaccinated against COVID-19 unless exempt. The IFC provides that individuals who provide services 100 percent remotely are not subject to the vaccination requirements; however, staff that primarily provide services remotely via telework who occasionally encounter fellow staff are still bound by the IFC’s provisions.
  • Background: On September 9, 2021 President Biden issued an executive order  (EO) entitled “Path out of the Pandemic,” a multifaceted COVID-19 response plan  that seeks to boost vaccinations and testing amid the surge in the delta variant. The President’s new plan focuses on six core components, including: (1) “Vaccinating the Unvaccinated;” (2) “Further Protection for the Vaccinated;” (3) “Keeping Schools Safely Open;” (4) “Increased Testing and Requiring Masking;” (5)  “Protecting Our Economic Recovery”; and (6) “Improving Care for Those with COVID-19.” To further the mission of this EO, CMS and the Occupational Health Services Administration (OSHA) issued regulations requiring certain individuals in the workforce to be vaccinated against COVID-19. In today’s IFC, CMS indicates that providers and suppliers may be covered by both the OSHA rules and the CMS IFC.
CMS is providing two implementation phases for the IFC in order to ensure efficiency in carrying out these requirements — effective 30 and 60 days after publication of this IFC in the Federal Register for Phases 1 and 2, respectively. The IFC notes that non-compliant facilities may be subject to civil money penalties, denial of payment for new admissions, or termination of their Medicare and Medicaid provider agreement. The agency also stated that it intends to retain these provisions beyond the conclusion of the public health emergency (PHE) as relevant, adding that it may deem these provisions permanent for facilities. To this end, CMS highlighted that this rulemaking is not associated with or tied to the PHE declarations, nor is there a sunset clause.
  • What’s Next? The final rule is expected to be published in the Federal Register on November 5, 2021, with an expected effective date of January 4, 2022. Comments to the IFC must be received no later than 60 days after the publication of the IFC in the Federal Register. While legal challenges to these guidelines are expected, CMS has already notably indicated in today’s IFC that, to the extent a court may enjoin any part of the rule, it intends that all other provisions or parts of provisions are to remain in effect.
Key policy items outlined in the IFC include:
  • Applicable Entities — The IFC provides that Medicare- and Medicaid-certified providers and suppliers must require that all applicable staff are fully vaccinated for COVID-19. Specifically, the entities subject to these requirements include:
    1. ambulatory surgical centers (ASCs);
    2. hospices;
    3. psychiatric residential treatment facilities (PRTFs);
    4. programs of all-inclusive care for the elderly (PACE);
    5. hospitals, including acute care hospitals, psychiatric hospitals, long term care hospitals, children’s hospitals, hospital swing beds, transplant centers, cancer hospitals, and rehabilitation hospitals;
    6. long term care (LTC) facilities, including skilled nursing facilities (SNFs) and nursing facilities (NFs);
    7. intermediate care facilities for individuals with intellectual disabilities (ICFs-IID);
    8. home health agencies (HHAs);
    9. comprehensive outpatient rehabilitation facilities (CORFs);
    10. critical access hospitals (CAHs);
    11. clinics, rehabilitation agencies, and public health agencies as providers of outpatient physical therapy and speech-language pathology services;
    12. community mental health centers (CMHCs);
    13. home infusion therapy (HIT) suppliers;
    14. rural health clinics (RHCs)/federally qualified health centers (FQHCs); and
    15. end-stage renal disease (ESRD) facilities.
  • In the IFC, CMS refers to the above facilities as residential congregate-care facilities, acute care settings, outpatient clinical care and services, and home-based care, generally. Notably, the requirements outlined in the IFC do not apply to assisted living facilities, group homes, or physician’s offices because they are not regulated by CMS health and safety standards.
  • Applicable Staff — CMS is requiring that all staff, regardless of patient contact or clinical responsibility, be fully vaccinated against COVID-19. The IFC stipulates that facility employees; licensed practitioners; students, trainees, and volunteers; and individuals who provide care, treatment, or other services for the facility and/or its patients, under contract or other arrangement, are subject to this requirement. The agency notes that staff who perform their duties outside of a formal clinical setting — such as home health, home infusion therapy, hospice, PACE programs, and therapy staff — are not precluded from the rule. Further, CMS asserts that individuals who provide services 100 percent remotely — including fully remote telehealth or payroll services — are not subject to the vaccination requirements. However, staff that primarily provide services remotely via telework who occasionally encounter fellow staff are still bound by the rulemaking.
  • Definition of “Fully Vaccinated” — Under the IFC, an individual is considered to be “fully vaccinated” if it has been two weeks or more since such individual completed a primary vaccination series defined as a single-dose or all doses of a multi-dose vaccine approved by the Food and Drug Administration (FDA). Importantly, individuals who receive vaccines listed by the World Health Organization (WHO) for emergency use but have not been approved or authorized by the FDA will also be counted as fully vaccinated for the purposes of the rulemaking. Additionally, individuals are not required to receive a booster or third dose of a vaccine in order to be considered fully vaccinated. However, providers and suppliers covered by the IFC must have a process for tracking and securely documenting the vaccination status of individuals who have obtained any booster.
  • Exceptions — CMS is requiring that applicable providers and suppliers establish and implement a process to allow staff to request an exemption from COVID-19 vaccination requirements based on applicable Federal law. The agency cites certain allergies; recognized medical conditions; or religious beliefs, observances, or practices as possible grounds for exemption. Providers and suppliers covered by the IFC are also required to document exemption requests from the vaccine requirements as well as the outcomes of those requests. Further, the agency is requiring that all applicable providers and suppliers establish a process to ensure the implementation of additional precautions to mitigate the transmission of COVID-19 for all staff who are not fully vaccinated. Notably, CMS expressly preserves an employer’s right to require that employees be fully vaccinated, regardless of the exemptions provided by the IFC.
  • Implementation — CMS is providing two implementation phases for the IFC in order to ensure efficiency in carrying out these requirements.
    • Phase 1. This phase includes a large majority of provisions in the IFC, including requirements that: (1) all staff have received at least the first dose of the COVID-19 vaccine, or a single dose COVID-19 vaccine, or have requested and/or been granted a lawful exemption to the requirement and (2) facilities have developed and implemented the aforementioned policies and procedures. Phase 1 is effective 30 days after the publication of this IFC in the Federal Register.
    • Phase 2. This phase requires that all applicable staff are fully vaccinated for COVID-19, unless granted an exception, which must be fully approved at this phase. Staff who have completed a primary vaccination series by this date are considered to have met these requirements, even if they have yet to complete the 14-day waiting period required for full vaccination. Phase 2 is effective 60 days after the publication of this IFC in the Federal Register.
  • Enforcement — CMS plans to issue interpretive guidelines, which include state survey procedures, to aid in assessing compliance with the new requirements among providers and suppliers following the publication of this IFC. The agency provides that non-compliant facilities may be subject to civil money penalties, denial of payment for new admissions, or termination of their Medicare and Medicaid provider agreement.
  • Other Provisions — This rule does not provide any prevention and control requirements for PRTFs, RHCs/FQHCs, and HIT suppliers. However, it does require that these entities create procedures in accordance with nationally recognized guidelines to limit the spread of COVID-19. Further, this IFC requires that providers and suppliers retain proper documentation of the vaccination status of each staff member, such as: (1) CDC COVID-19 vaccination card or legible photo of the card; (2) documentation of vaccination from a health care provider or electronic health record; or (3) a state immunization information system record.
[/vc_column_text][/vc_column][/vc_row]

Behavioral Health Slides from MACPAC’s April 2021 Public Meeting

HHS Announces Delay in Provider Relief Fund Reporting Deadline and Revisions to ‘Lost Revenue’ Definition

The U.S. Health and Human Services Department (HHS) has announced a new reporting portal for providers to register and submit information about how they have used payments from the Provider Relief Fund (PRF) to cover Covid-19-related costs and lost revenues. HHS also said the deadline for reporting is extended, although it did not specify the deadline. The agency said providers can register and become familiar with the reporting portal in the meantime. Previously HHS said that providers who received payments amounting to more than $10,000 from the PRF were required to report by Feb. 15, 2021 on how they used those funds. The department had also said providers had until July 31, 2021 to report on funds not expended by the end of 2020. Late last month, Congress passed the Coronavirus Response and Relief Supplemental Appropriations Act, which added $3 billion to the PRF. This legislation changed the reporting requirements to allow more flexibility in how providers may use PRF funds to cover lost revenues. HHS said in its recent announcement that it is updating PRF reporting requirements to align with the new law. The department highlighted reporting requirement changes in the highlighted section of this document.

NABH-The Kennedy Forum Op-Ed

In January, the Centers for Disease Control and Prevention announced some hopeful news when it reported a slight uptick in U.S. life expectancy following years of decline largely due to historic rates of overdoses and suicides. Sadly, COVID-19 has the potential to reverse serious progress made in addressing our nation’s mental health and addiction crises — particularly around overdose rates — unless policymakers mitigate the pandemic’s serious effects on behavioral health in the next stimulus package. Read More

CMS Releases Guidance on Coverage Transition for ‘Dual Eligibles’ Receiving OTP Services

The Centers for Medicare & Medicaid Services (CMS) released an Informational Bulletin on Tuesday that provides guidance on coverage for Medicare and Medicaid dual-eligible beneficiaries who receive opioid treatment program (OTP) services. Revisions to the Physician Fee Schedule (CY 2020) allow for a new OTP bundled payment benefit under Medicare, which replaces Medicaid as the primary payer for OTP services for the dual-eligible population. The new benefit is effective January 1, 2020; however, not all OTP providers will have completed Medicare enrollment by that time. To assure continuity of patient care, states must pay OTP claims for Medicaid state plan covered services for Medicaid enrolled providers while Medicare enrollments are being completed. The new guidance from CMS provides information to state Medicaid agencies about strategies for continuing to pay for OTP services, including continuing to pay for claims for a specified period, and advising OTPs to submit claims only after their Medicare enrollment has been approved. CMS recommends that states communicate with Medicaid managed care plans that cover OTP benefits, as well as with providers to advise them to enroll in Medicare. If you have questions, please contact Sarah Wattenberg, NABH’s director of quality and addiction services.

Behavioral Health Update: January 7, 2019

============================= BEHAVIORAL HEALTH UPDATE A Monthly Report for Members of the American Hospital Association and the National Association for Behavioral Healthcare www.aha.org www.nabh.org January 2019    Updates:
  1. CMS Reports Healthcare Spending Growth Slowed Last Year
  2. HRSA Releases Behavioral Health Workforce Projections
  3. CMS Features FAQ on Price Transparency Provision in IPPS
  4. CMS Requests Feedback on Conflict of Interest at Accrediting Organizations
  5. Behavioral Health IT Coalition Sends Letter to CMS
  6. RAND Report Analyzes Heroin-Assisted Treatment and Supervised Drug Consumption Sites
  7. AMA Study Examines Association Between Psychotic Experiences and Risk of Suicide
  8. MACPAC Releases 2018 Edition of MACStats: Medicaid and CHIP Data Book
  9. PwC Health Research Institute Previews Top Health Industry Issues for 2019
  10. CDC’s NVSR Reports on Drugs Most Frequently Used in Overdoses: 2011-2016
  11. PCORI Board Approves $12.7 million for Mental Health Research Study
  12. U.S. Preventive Services Task Force Seeks Comments on Opioid Interventions
  13. CMMI Posts Fact Sheet on Integrated Care for Kids and Maternal Opioid Misuse Models
  14. Manatt, AMA & Pennsylvania Medical Society Release Report on Practices to End Opioid Crisis
  15. CHCS and ACAP Release Report on Social Determinants of Health via Medicaid Managed Care
  16. Associations Among Motor Activity, Sleep, Energy & Mood Could Suggest New Focus for Depression Treatment
  17. NIDA Highlights Details for National Drug and Alcohol Facts Week
  18. World Congress to Host Opioid Management Summit in February
  19. Register Today for 2019 Annual Meetings
Stories: 1. CMS Reports Healthcare Spending Growth Slowed Last Year Total nominal U.S. healthcare spending increased 3.9 percent to $3.5 trillion in 2017, slowing down from growth of 4.8 percent in 2016, the Centers for Medicare and Medicaid (CMS) reported last month. The new statistics were published in an article in Health Affairs which reported that the rate of growth in 2017 was similar to the increases between 2008 and 2013, which preceded a faster growth rate between 2014 and 2015—a period that included insurance coverage expansion and large increases in prescription drug spending. According to the analysis, nearly all major sources of insurance and sponsors of healthcare experienced slower growth last year. Meanwhile, the share of gross domestic product devoted to healthcare spending was 17.9 percent in 2017, similar to the share in 2016.   2. HRSA Releases Behavioral Health Workforce Projections About 276,400 people are expected to enter the behavioral health workforce during the five-year period between 2016 and 2021, HHS’ Health Resources and Services Administration (HRSA) estimates in a new analysis. The findings are part of HRSA’s Behavioral Health Workforce Projections that the agency compiled following a mandate from the 21st Century Cures Act. In the analysis, HRSA provides national-level workforce estimates for the following occupations between 2016 and 2030: addiction counselors, marriage and family therapists, mental health and school counselors, psychiatric technicians and psychiatric aides, psychiatric nurse practitioners and psychiatric physician assistants, psychiatrists, psychologists, and social workers. According to a 2017 report from the Substance Abuse and Mental Health Services Administration (SAMHSA), nearly one in five adults in the United States—or about 44.7 million people—suffered from a mental illness in the last year, and in 2016 about 28.6 million people aged 12 and older used an illicit drug in the past 30 days. “Beyond the direct toll on individuals and families,” HRSA noted on its website, “mental illness and substance use disorders are well-established drivers of disability, mortality, and healthcare costs.” The HRSA analysis also included state-level behavioral health workforce estimates.   3. CMS Features FAQ on Price Transparency Provision in IPPS  CMS has released two FAQ (here and here) documents on the Affordable Care Act (ACA) requirement that all hospitals establish, update, and publish publicly online a list of the hospital’s “standard charges” for services the hospital provides. CMS included this ACA provision—which becomes effective Jan. 1, 2019—in its final FY 2019 inpatient prospective payment system (IPPS) rule. The final rule did not include a definition of “standard charge,” but CMS noted that hospitals can make public a chargemaster “or another form of the hospital’s choice.” CMS also said the form must be in a “machine-readable” format and added that PDF documents are not considered permissible under that definition.   4. CMS Requests Feedback on Conflict of Interest at Accrediting Organizations The Centers for Medicare and Medicaid Services (CMS) last month requested public comment about the appropriateness of some Medicare-approved accrediting organizations (AO) offering fee-based consultative services to providers and suppliers they also accredit as part of their business model. “CMS is seeking to receive stakeholder input which can help us determine whether the AO practices of consulting with the same facilities which they accredit could create actual or perceived conflicts of interest between the accreditation and consultative functions of the AO,” the agency said in its announcement, adding that it will consider the information it receives to help with future rulemaking.   5. Behavioral Health IT Coalition Sends Letter to CMS In a letter to CMS last month, the Behavioral Health IT Coalition said mental health and addiction treatment providers participating in the Centers for Medicare and Medicaid Innovation (CMMI) MAT bundled payment models outlined in the new law must show e-prescribing capacity. It also said behavioral health facilities must provide evidence that they can exchange clinical data successfully with medical-surgical providers in order to be eligible for funding through these demonstrations. The final recommendation said CMS should incorporate health IT financial incentives into each of the three MAT demonstrations to urge behavioral health and substance use disorder (SUD) providers to adopt 2015 certified electronic health record technology.   6. RAND Report Analyzes Heroin-Assisted Treatment and Supervised Drug Consumption Sites A new report from RAND Corp. examines how four countries use two interventions that the United States does not apply to address opioid use disorder: heroin-assisted treatment (HAT) and supervised consumption sites (SCSs). “Give the severity of the opioid crisis, there is urgency to evaluate potential tools that might reduce its impact and save lives,” the report said. “This working paper is part of a series of reports assessing the evidence on and arguments made about HAT and SCSs and examining some of the issues associated with implement in the United States.”   7. JAMA Study Examines Association Between Psychotic Experiences and Risk of Suicide Individuals with psychotic experiences are at increased risk of suicidal ideation, suicide attempts, and suicide death, according to a new JAMA study.   Recent research has shown a particularly strong association between psychotic experiences and suicidal behavior. This study’s purpose was to provide a quantitative synthesis of the literature examining the longitudinal association between psychotic experiences and subsequent “suicidal ideation, suicide attempts, and suicide deaths in the general population.”   8. MACPAC Releases 2018 Edition of MACStats: Medicaid and CHIP Data Book The Medicaid and CHIP Payment and Access Commission (MACPAC) last month released the December 2018 edition of its MACStats: Medicaid and CHIP Data Book, which has updated data on national and state Medicaid and CHIP enrollment, spending, benefits, and more. This year’s edition shows total enrollment growth in Medicaid and the State Children’s Health Insurance Program (CHIP) decreased 2.2 percent nationally from July 2017 to July 2018.   9. PwC Health Research Institute Previews Top Health Industry Issues for 2019 In its annual forecast, PwC Health Research Institute predicts that providers and payers that have served Medicaid patients will have a significant effect on the healthcare industry in the New Year. “In 2019 the health industry will see value lines created by innovative providers and payers that have figured out how to subsist—comfortably, thank you very much—by serving almost entirely Medicaid or cash-strapped patients,” the report noted. PwC’s 54-page analysis—The New Health Economy Comes of Age—also predicts that life sciences companies will market digital therapeutics and connected devices targeting atrial fibrillation, hemophilia, substance abuse, birth control, depression, diabetes, epilepsy and other conditions. “Once thought to operate outside the greater U.S. economy, the industry—with its byzantine payment system, complicated regulatory barriers and reliance on face-to-face interactions—is being disrupted,” the report noted. “Finally, there’s robust evidence that what PwC calls the New Health Economy is kicking into gear.” According to PwC’s analysis, 84 percent of Fortune 50 companies are involved with healthcare, and venture capital funding for digital health startups is projected to top $6.9 billion in 2018, reflecting a 230-percent increase from five years ago. Meanwhile, the report noted that “American consumers have told PwC’s Health Research Institute since 2013 that they’re “eager to embrace more convenient, digitally enabled and affordable care; finally, they’re finding it, with options that resemble the choices they have in other parts of their lives.”   10. CDC’s NSVR Reports on Drugs Most Frequently Used in Overdoses: 2011-2016 Fentanyl, heroin, hydrocodone, methadone, morphine, oxycodone, alprazolam, diazepam, cocaine, and methamphetamine were the 10 most frequently mentioned drugs among drug overdose deaths that noted at least one specific drug between 2011 and 2016, according to the Centers for Disease Control and Prevention’s (CDC) National Vital Statistics Report (NVSR). Oxycodone ranked first in 2011; heroin during 2012-2015; and fentanyl in 2015. During the study period, cocaine consistently ranked second or third, researchers found. The report’s conclusion said these findings highlight “the importance of complete and accurate reporting in the literal text on death certificates.” 11. PCORI Board Approves $12.7 million for Mental Health Research Study The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors last month approved $12.7 million to fund a study that will examine the effectiveness of different strategies to treat anxiety and depression in expectant and new mothers. Funding will go to researchers in Chapel Hill, N.C.; Chicago; and Toronto to study four different methods of providing treatment, in-person sessions with either a specialist provider or nurse, or the same sessions delivered via telemedicine. “Depression and anxiety symptoms pose a significant burden and lead to high costs among mothers worldwide,” PCORI noted in an announcement about the study. “Psychological treatments—also known as talk therapies, including behavioral, cognitive and interpersonal therapies—have a robust evidence base and are preferred by women and their families over pharmacological treatments,” the announcement continued. “Unfortunately, as few as one in five women can access these effective treatments due to a dearth of available specialists and barriers including cost, transportation, and access. There is therefore a need for widely accessible, low-cost, and innovative psychological treatments for depression and anxiety during pregnancy and postpartum.” Click here to learn about the project’s details. 12. U.S. Preventive Services Task Force Seeks Comments on Opioid Interventions The U.S. Preventive Services Task Force (USPSTF) last month opened the public comment period for its draft research plan on interventions to prevent opioid use disorder. The USPSTF notes clearly that the plan is in draft form and has been distributed for the sole purpose of gaining feedback. The task force will accept public comments through Wednesday, Jan. 16, 2019 at 8 p.m. ET. 13. CMMI Posts Fact Sheet on Integrated Care for Kids and Maternal Opioid Misuse Models The Center for Medicare and Medicaid Innovation (CMMI) has posted a fact sheet on its Integrated Care for Kids (InCK) and Maternal Opioid Misuse, or MOM, Models designed to improve care delivery and reduce expenditures for Medicaid and Children’s Health Insurance Program (CHIP) beneficiaries affected by the nation’s opioid crisis. “By catalyzing state-driven care transformation and aligning financial incentives, both models aim to improve health outcomes and address fragmentation of care for affected beneficiaries,” the Innovation Center noted. “Ultimately, the InCK and MOM models aim to enable better coordination of clinical care and the integration of other services critical for health, wellbeing, and recovery.” 14. Manatt, AMA & Pennsylvania Medical Society Release Report on Practices to End Opioid Crisis Manatt Health, the American Medical Association (AMA), and the Pennsylvania Medical Society last month released a report that examines what Pennsylvania has accomplished in the areas of substance use disorder treatment, pain management, and harm reduction to combat the opioid crisis. The report focuses on the work of two agencies—the Pennsylvania Medicaid agency and the Pennsylvania Insurance Department—and highlights in particular Pennsylvania’s broad support for Medication Assisted Treatment (MAT), parity law enforcement, and comprehensive naloxone access. Researchers also included recommendations on how Pennsylvania can “build on its successes, including expanding efforts in emergency departments and law enforcement to link patients to high-quality care, and requiring insurers to enhance access to non-opioid care so that patients have alternative treatments as opioid prescriptions are reduced.” 15. CHCS and ACAP Release Report on Social Determinants of Health via Medicaid Managed Care The Center for Health Care Strategies (CHCS) and the Association for Community Affiliated Plans (ACAP) last month released findings of a nationwide review of Medicaid managed care contracts and section 1115 demonstrations to identify common themes in state approaches to incentivizing and requiring social determinant of health-related activities (SDOH). Addressing Social Determinants of Health via Medicaid Managed Care Contracts and Section 1115 Demonstrations includes five specific policy recommendations from CHCS to support SDOH activities: make  it easier for vulnerable populations to access needed health services; enhance agency collaboration at the federal level; provide guidance on addressing SDOH through managed care; approve section 1115 demonstrations that test strategies to address SDOH; and support outcomes-based payment for SDOH interventions.   16. Associations Among Motor Activity, Sleep, Energy & Mood Could Suggest New Focus for Depression Treatment Instability in activity and sleep systems could lead to mood changes—which could suggest new approaches for depression treatment, according to new findings published online in the journal JAMA Psychiatry. Current theories of depression suggest that sleep problems, low energy, and low activity levels result from depressed mood, but this new study that examines these factors among people with bipolar disorder or depression suggest the opposite may be true, the National Institute of Mental Health noted in its announcement about the study. Researchers “discovered a unidirectional relationship between motor activity and mood, suggesting that motor activity affects subsequent mood, but that mood does not affect subsequent motor activity and sleep systems could lead to mood changes,” the NIH posting said. 17. NIDA Highlights Details for National Drug and Alcohol Facts Week  The National Institute on Drug Abuse (NIDA) has posted information about National Drug and Alcohol Facts Week, a national health observance from Jan. 22–27, 2019 that will link teens to science-based facts about drugs. NIDA’s website features details about hosting an event, an online teaching guide, free materials, activity ideas and toolkits, and more. 18. World Congress to Host Opioid Management Summit in February World Congress—which hosts conferences and events in healthcare, life sciences, and pharmaceuticals—will host its third annual Opioid Management Summit at the Wink Hotel in Washington, D.C. from February 26-27, 2019. A panel discussion titled Ensure Resources and an Integrated Care Continuum Support Treatment and Recovery will be hosted on the second day of the conference. Click here to learn more and register for the meeting.   19. Register Today for 2019 Annual Meetings The National Association for Behavioral Healthcare (NABH) and the American Hospital Association (AHA) have posted the dates for their 2019 Annual Meetings in Washington, D.C. NABH will host its Annual Meeting from March 18-20, 2019 at the Mandarin Oriental Washington, DC, and the AHA will host its Annual Meeting from April 7-10, 2019 at the Marriott Marquis. Jessica Zigmond prepared this edition of Behavioral Health Update. Feel free to give us your feedback, stories, and suggestions:  NABH:  Jessica Zigmond, NABH, jessica@nabh.org, 202.393.6700, ext. 101; AHA:  Rebecca Chickey, AHA SPSAS, rchickey@aha.org, 312.422.3303 Copyright 2019 by the American Hospital Association and the National Association for Behavioral Healthcare. All rights reserved.  For republication rights, contact Jessica Zigmond.  The opinions expressed are not necessarily those of the American Hospital Association or of the National Association for Behavioral Healthcare.

NABH Seeks 2019 Board Nominations

As the Selection Committee prepares to consider possible nominees, we would like you to help us identify potential candidates for:
  • the position of Board Chair-Elect and
  • two Board seats that will become available in 2019.
The Selection Committee is particularly interested in identifying senior managers who represent the broad diversity within the NABH membership, including diverse levels of care, organizational structures, and more. Please download a nomination form to share your recommendations of individuals who you would like to see the Selection Committee include in the single-slate ballot for 2019. Please attach a curriculum vita (CV) for each individual you recommend. This will help the Selection Committee in its deliberations. You are welcome to suggest yourself or others.
Please return this form (and candidates’ CVs) by Wednesday, October 31, 2018, to maria@nabh.org (or mail to NABH, ATTN: Maria Merlie, 900 17th Street, NW, Suite 420, Washington, DC 20006). Immediate Past Board Chair Debbie Osteen will chair the NABH Selection Committee, which will meet this fall to develop the final slate.  

Signature Healthcare Services’ Aurora San Diego Hospital Hosts Congressional Site Visit

NABH Member Hosts Congressional Site Visit

NABH member Signature Healthcare Services’ Aurora San Diego hospital recently hosted Rep. Scott Peters (D-Calif.), who toured the facility and met with hospital leaders to discuss some the biggest challenges facing the behavioral healthcare industry.

Aurora San Diego provides mental health and substance abuse services both on an inpatient and outpatient basis for children, adolescents, adults and older adults. Aurora also has a highly regarded military treatment program for active duty members who are working through combat-related trauma, general mental health issues and substance use disorders.

Rep. Peters and hospital leaders discussed addressing the opioid crisis and removing some outdated federal barriers to care, including the Institutions for Mental Diseases (IMD) exclusion that prevents adult Medicaid beneficiaries from accessing acute care in facilities with more than 16 beds, and Medicare’s 190-day lifetime limit on inpatient care in a psychiatric hospital.

Following his tour, Rep. Peters hosted a Town Hall-style meeting with about 50 Aurora employees from across all disciplines to discuss the need for more resources to address mental health for service members and veterans.

For information and help coordinating a congressional site visit, please contact Julia E. Richardson, NABH’s director of advocacy and senior counsel, at julia@nabh.org.